The Clinical Utility of Circulating Tumor Cells in Cancer Therapy

摘要

Circulating tumour cells (CTCs) and DNA (ctDNA) have enormous translational potential to alter the clinical management of cancer treatment. We recently established a CTC facility focused on blood-based assays for the analysis of cancer-associated biomarkers. Our research interest is on the development and application of CTCs and ctDNA based assays that can be translated into the clinical setting to improve chemotherapeutic monitoring and patient management, with the ultimate goal of enhancing patient outcomes.